The management provided an overview of the Company's business operations, financial performance, strategic initiatives and future growth prospects during the webinar. Key highlights discussed include:
- The Company highlighted consistent financial performance since listing with year-on-year growth in revenue and Profit After Tax (PAT)
- Reiterated long-term revenue target of approximately ₹400 crore by FY2028
- Management shared updates on expansion of oncology business, including dedicated cancer hospital
- Cardiology, oncology and neurosurgery are expected to be key growth drivers in coming years
- Company is in process of submitting bid for establishment of 100-seat Medical College under Public-Private Partnership (PPP) model
- Establishing nursing and paramedical colleges to strengthen integrated healthcare ecosystem
- Shared updates on proposed Bone Marrow Transplant (BMT) Facility
- Discussed operational performance, occupancy targets, doctor retention strategy and evolving business mix
- Company has initiated preparatory activities for migration to Main Board, subject to fulfilment of applicable eligibility criteria and receipt of necessary regulatory approvals
- Evaluating acquisition of 70 bed hospital to strengthen regional presence
The company confirmed that no Unpublished Price Sensitive Information (UPSI), as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015, was shared or discussed during the webinar. All information shared was based on information already available in the public domain and/or previously disclosed by the Company.